Robert Hermann
6Patents
2h-index
11Co-inventors
44Inventor score
Filing activity: May 5, 1995 → Mar 12, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5578634A | 1H-indole-3-acetic acid hydrazide sPLA.sub.2 inhibitors | Chemistry; Metallurgy | 23 | Expired |
| US5684034A | 1H-indole-3-acetamide sPLA.sub.2 inhibitors | Chemistry; Metallurgy | 16 | Expired |
| US6252084A | 1H-indole-3-acetamide sPLA2 inhibitors | Chemistry; Metallurgy | 2 | Expired |
| US6545039B1 | Facilitated administration of &agr;-lipoic acid or derivatives thereof | Human Necessities | 2 | Expired |
| US8557851B2 | Combinations of flupirtine and sodium channel inhibiting substances for treating pains | Human Necessities | 0 | Active |
| US7799832B2 | Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.